ActionTilson North West
patrickmyles London
KateK2 North West
Kamlat1 London
Debrahindley Yorkshire And Humberside
sarahmccarthy001 London
PTC Therapeutics has completed patient enrollment of a pivotal clinical trial of ataluren in patients with nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD) two months ahead of ...
Tags: ataluren, nonsense mutation, PTC124, PTC Therapeutics.